ahlam1399
07-20-2016, 02:13 AM
UPDATE 1-Zafgen to scrap lead obesity drug, cut jobs
July 19 (Reuters) - Zafgen Inc said it wassuspending the development of its lead obesity drug, beloranib,more than six months after the U.S. Food and Drug Administrationasked the company to halt...http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=tqM7pWwMsOI:iGnlXeDL7-Q:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=tqM7pWwMsOI:iGnlXeDL7-Q:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=tqM7pWwMsOI:iGnlXeDL7-Q:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=tqM7pWwMsOI:iGnlXeDL7-Q:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=tqM7pWwMsOI:iGnlXeDL7-Q:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/tqM7pWwMsOI
July 19 (Reuters) - Zafgen Inc said it wassuspending the development of its lead obesity drug, beloranib,more than six months after the U.S. Food and Drug Administrationasked the company to halt...http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=tqM7pWwMsOI:iGnlXeDL7-Q:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=tqM7pWwMsOI:iGnlXeDL7-Q:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=tqM7pWwMsOI:iGnlXeDL7-Q:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=tqM7pWwMsOI:iGnlXeDL7-Q:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=tqM7pWwMsOI:iGnlXeDL7-Q:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/tqM7pWwMsOI